The Dutch medtech company Surge-on Medical, which has developed a platform technology that is intended to set new standards in precision and robotic surgery, is making a start with its financing campaign.

The campaign kick-off for Surge-on Medical marks the start of a new way of public venture funding in Europe. For the first time, a cross border crowdfunding campaign based on a prospectus-approved securities offering enables private investors to invest online alongside with business angels and venture capitalists to benefit from the growth potential of early-stage growth companies. “Our ambition was, to let not stop public funding of healthcare ventures at national borders”, commented Dr. Patrick Pfeffer, CEO & founder of Aescuvest. “After the successful launch of the Surge-on Medical funding, we are looking forward to soon be able to present a series of exciting health innovators from all over Europe on”

Jan-Philipp Beck, CEO of EIT Health – partner of Aescuvest – added: The goal of EIT Health is to contribute to a stronger health ecosystem in Europe. The cooperation with is a cornerstone for our mission, to support the most promising start-up companies out of our network to scale-up their business by a funding that is combined with a high visibility in the market, and thus to help European entrepreneurs to increase their global competitiveness.”  

Project open for investments – Surge-on Medical targets to raise up to €5 million

During the event, the go-ahead was given for the financing campaign of Surge-on Medical. The rising star in the segment of surgical instruments is developing and selling fully steerable, quick detachable and easy to clean instruments for minimal invasive arthroscopy and laparoscopy. The company is setting new surgery standards to deliver better healthcare. Using cable-free technologies, they have created freedimensionally movable instruments that provide better access to surgical areas and replace the current fixed-angle instruments.

Via the company now intends to raise up to €5 million by ways of a prospectus-based security offering, corresponding to a 12.74 % share in the company. Investments will be bundled in an SPV, that will become one shareholder of the company and as such will fully participate in the value development of Surge-on Medical.

During the launch phase of the platform, you can invest in Surge-on Medical’s campaign starting from as little as €500 and become part of this innovation in the European healthcare market.

More information on the campaign and Aescuvest’s Equity Crowdfunding model can be found on the Surge-on Medical funding page and in the FAQs.

Your guide

to pan-European equity crowdfunding.
Get your free ebook now.

By clicking on 'Sign up', you agree to receive the newsletter with information on, for example, our services, our company as well as to its analysis through individual measurement, storage and evaluation of opening rates and click rates in recipient profiles for the purpose of designing future newsletters according to the interests of our readers. Consent can be revoked with effect for the future. Detailed information is available in our data privacy terms.